Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-3,page-paged-3,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.1,vc_responsive

CLIENT NEWS

 

 

  • CENTOGENE Announces Global Expansion of COVID-19 Testing
    www.centogene.com
  • MagForce AG Publishes Shareholder Letter
    www.magforce.de
  • Newron Reports Top-Line Results from its STARS Study Evaluating Sarizotan in Patients with Rett Syndrome
    www.newron.com
  • Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020
    www.veronapharma.com
  • InflaRx Reports Full Year 2019 Financial & Operating Results
    www.inflarx.de
  • Secarna Pharmaceuticals enters into cooperation with Guangzhou’s Sun Yat-sen University to develop a treatment for SARS-CoV-2 viral infections
    www.secarna.com
  • MagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Protocol for the next Stage of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System
    www.magforce.de
  • CEVEC Announces the Launch of the ELEVECTA® Platform – the Stable Producer Cell Line Technology for AAV Gene Therapy Vectors
    www.cevec.com
  • Heidelberg Pharma AG Raises EUR 14.4 Million From Private Placement
    www.heidelberg-pharma.com
  • Heidelberg Pharma AG Plans Capital Increase to Fund Its ATAC Development Program
    www.heidelberg-pharma.com